Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025)
Oramed Pharmaceuticals (ORMP) posted Minority Interest of -$952000.0 for Q3 2025, down 0.63% on a QoQ basis from -$946000.0 in Q2 2025, and down 3.59% year-over-year from -$987458.2 in Q3 2024.
Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025) Analysis & Trends
Oramed Pharmaceuticals' Minority Interest history runs 5 years deep, the most recent figure standing at -$952000.0 for Q3 2025.
- Quarterly Minority Interest fell 3.59% year-over-year to -$952000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$952000.0 (down 3.59% YoY) and the FY2024 annual result came in at -$918000.0, up 1.08% from the prior year.
- Minority Interest was -$952000.0 for Q3 2025 at Oramed Pharmaceuticals, down from -$946000.0 in the prior quarter.
- Across five years, Minority Interest topped out at $1.1 million in Q2 2021 and bottomed at -$952000.0 in Q3 2025.
- A 5-year average of -$542833.3 and a median of -$896500.0 in 2023 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2023 — Minority Interest sank 552.38% — and 2024, when it advanced 1.08%.
- Oramed Pharmaceuticals' Minority Interest stood at $536000.0 in 2021, then sank by 222.39% to -$656000.0 in 2022, then tumbled by 41.46% to -$928000.0 in 2023, then increased by 1.08% to -$918000.0 in 2024, then retreated by 3.7% to -$952000.0 in 2025.
- Business Quant data shows ORMP's Minority Interest at -$952000.0 in Q3 2025, -$946000.0 in Q2 2025, and -$918000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -952,000.00 |
| Jun 30, 2025 | -946,000.00 |
| Mar 31, 2025 | -918,000.00 |
| Dec 31, 2024 | -918,000.00 |
| Sep 30, 2024 | -919,000.00 |
| Jun 30, 2024 | -911,000.00 |
| Mar 31, 2024 | -918,000.00 |
| Dec 31, 2023 | -928,000.00 |
| Sep 30, 2023 | -902,000.00 |
| Jun 30, 2023 | -891,000.00 |
| Mar 31, 2023 | -822,000.00 |
| Dec 31, 2022 | -656,000.00 |
| Sep 30, 2022 | -661,000.00 |
| Jun 30, 2022 | -660,000.00 |
| Mar 31, 2022 | -126,000.00 |
| Nov 30, 2021 | 536,000.00 |
| Aug 31, 2021 | 744,000.00 |
| May 31, 2021 | 1.08 Mn |